- Home
- PMCB vs SGLY Comparison
PMCB vs SGLY Comparison
Compare PMCB & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SGLY
- Stock Information
- Founded
- PMCB 1996
- SGLY 2001
- Country
- PMCB United States
- SGLY United States
- Employees
- PMCB N/A
- SGLY N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SGLY
- Sector
- PMCB Health Care
- SGLY
- Exchange
- PMCB Nasdaq
- SGLY Nasdaq
- Market Cap
- PMCB 11.4M
- SGLY 5.8M
- IPO Year
- PMCB N/A
- SGLY 2008
- Fundamental
- Price
- PMCB $1.64
- SGLY $1.55
- Analyst Decision
- PMCB
- SGLY
- Analyst Count
- PMCB 0
- SGLY 0
- Target Price
- PMCB N/A
- SGLY N/A
- AVG Volume (30 Days)
- PMCB 14.2K
- SGLY 14.2K
- Earning Date
- PMCB 12-31-2024
- SGLY 11-14-2024
- Dividend Yield
- PMCB N/A
- SGLY N/A
- EPS Growth
- PMCB N/A
- SGLY N/A
- EPS
- PMCB 0.74
- SGLY N/A
- Revenue
- PMCB N/A
- SGLY $2,742,157.00
- Revenue This Year
- PMCB N/A
- SGLY N/A
- Revenue Next Year
- PMCB N/A
- SGLY N/A
- P/E Ratio
- PMCB $2.21
- SGLY N/A
- Revenue Growth
- PMCB N/A
- SGLY N/A
- 52 Week Low
- PMCB $1.39
- SGLY $1.27
- 52 Week High
- PMCB $2.58
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- PMCB 45.24
- SGLY 43.10
- Support Level
- PMCB $1.60
- SGLY $1.58
- Resistance Level
- PMCB $1.69
- SGLY $1.71
- Average True Range (ATR)
- PMCB 0.11
- SGLY 0.09
- MACD
- PMCB -0.00
- SGLY -0.00
- Stochastic Oscillator
- PMCB 40.00
- SGLY 35.71
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.